Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 538 | 536 | 536 | 413 |
| Accounts receivable | -61 | -5 | 59 | -74 |
| Accounts payable and accrued liabilities | 176 | 53 | -12 | 40 |
| Other Working Capital | -551 | 24 | 80 | -145 |
| Other Operating Activity | -3,957 | -2,469 | -2,580 | -2,541 |
| Operating Cash Flow | $-3,855 | $-1,862 | $-1,917 | $-2,308 |
| Cash Flows From Investing Activities | ||||
| Net Acquisitions | N/A | N/A | 0 | 800 |
| Investing Cash Flow | $N/A | $N/A | $0 | $800 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 0 | 1,514 | N/A | N/A |
| Common Stock Issued | 4,920 | N/A | 0 | 4,295 |
| Other Financing Activity | -188 | -113 | 2 | 25 |
| Financing Cash Flow | $4,732 | $1,401 | $2 | $4,320 |
| Beginning Cash Position | 436 | 897 | 2,812 | 0 |
| End Cash Position | 1,313 | 436 | 897 | 2,812 |
| Net Cash Flow | $876 | $-461 | $-1,915 | $2,812 |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,855 | -1,862 | -1,917 | -2,308 |
| Free Cash Flow | -3,855 | -1,862 | -1,917 | -2,308 |